Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Laser Imaging System

By Drug Discovery Trends Editor | April 5, 2010

Carl Zeiss Laser TIRF3The Laser TIRF 3 microscope system from Carl Zeiss allows scientists to visualize near-cell membrane dynamic processes while maintaining optimum specimen incubation conditions. Single molecule dynamic processes in cell-free systems may also be observed. In combination with other techniques such as Atomic Force Microscopy (AFM), the microscope provides a solution for users in the life sciences, biochemistry, molecular biology and biophysics arenas.


A range of incubation options maintain viable conditions for live cell experiments. With the Definite Focus module, users can be assured of accurate quantitative data over long time periods. The new laser module may be equipped with up to four solid-state lasers, is AOTF-controlled (Acousto-Optical Tuneable Filter) and may be operated entirely from the AxioVision software interface.


The TIRF slider is available in two versions; either manual or fully-motorized and software controllable. The motorized version permits a given illumination angle to be set with greater accuracy and speed than other current systems and the reproducible angle setting results in reproducible penetration depths for the light beam. Together with the corrected beam-path and special filter sets, the apochromatically-corrected optics of the TIRF slider guarantee maximum image quality.


AOTF control and angle setting are integrated into the Fast Image Acquisition module of the AxioVision software, enabling significantly more high resolution images to be acquired within any given timeframe.


The new Laser TIRF 3 builds on the attributes of the Laser TIRF, the first microscope to offer the combination of TIRF and transmitted-light contrasting techniques, such as DIC and brightfield, and enable the sequential recording of image pairs. By selectively exciting cellular fluorophores adsorbed, adhered, or bound to the surface and combining it with conventional epi-fluorescence, researchers can relate surface effects to internal cellular structures.



Carl Zeiss  


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE